Migsun

Medicinal product

(Invented) name

Migsun

Active substance (s)

Sumatriptanas/Naprokseno natrio druska

Strength

85 mg/500 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N02CC, Selective serotonin (5HT1) agonists

Marketing authorisation holder

Orion Corporation, Suomija

Date of authorisation

2022-06-23

Date of renewal

Documents

4977 Pakuotės lapelis 2024 12 20.docx

4977 Migsun PCS 2025 05 25.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10b

Procedure number

FI/H/1108/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Sumatriptanas	85 mg
Naprokseno natrio druska	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108891	94997	1094997	talpyklė	N9		Receptinis	LT/1/22/4977/001	Netiekiama	-	-	No	-	-
109426	95532	1095532	lizdinė plokštelė	N9		Receptinis	LT/1/22/4977/002	Tiekiama	-	-	No	-	-	Download
116228	102330	1102330	lizdinė plokštelė	N3		Receptinis	LT/1/22/4977/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-06-23	Registruotas